 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Michelle D. Owens, PhD, Division of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, Mailstop K-10, Atlanta, GA 30341-3724, 770-488-5014, mgo2@cdc.gov, Barbara Hatcher, PhD, Scientific and Professional Affairs, American Public Health Association, 800 I Street, NW, Washington, DC 20001, John Graham, American Diabetes Association, 1701 North Beauregard Street, Alexandria, VA 22311, Yvonne Green, RN, MSN, CNM, Office of Women's Health, Centers for Disease Control and Prevention, 1600 Clifton Road, D51, Atlanta, GA 30333, Kathleen Nolan, MPH, Prevention Policy, Association of State & Territorial Health Officials, 1275 K Street, Suite 800, Washington, DC 20005, and Ann Albright, RD, PhD, Diabetes Control Program, Department of Health Services, P.O. Box 942732, Sacramento, CA 94234-7320.
Diabetes is a serious health condition that affects women in all life stages. It is unique to women because it can affect the health of both a mother and her unborn children. With the increasing life span of women and the rapid growth of minority populations in the United States, the number of women at risk for diabetes and its complications will continue to rise. The Centers for Disease Control and Prevention along with its primary co-sponsors (American Diabetes Association, American Public Health Association, and the Association of State and Territorial Health Officials) have launched a new initiative to focus national attention on the unique impact diabetes has on women’s health across the life stages. The major objectives of the initiative are to: 1) assess and describe the burden of diabetes for women across the life stages; 2) develop recommendations for a public health action plan and a description of implementation plans; and 3) a call to action. In this session, the presenter will summarize the recommendations for a public health action plan and co-sponsors of the initiative will respond to these summaries. At the conclusion of the session, the participants in this session will be able to: 1) identify the current status of the Diabetes & Women's Health Initiative; 2) discuss the recommended strategies and policies for public health action; and 3) identify opportunities to address the unique needs of women with diabetes.
Learning Objectives: At the conclusion of the session, the participants in this session will be able to
Related Web page: www.cdc.gov/diabetes/projects/women.htm
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: Centers for Disease Control, American Public Health Association, American Diabetes Association, Association of Territorial Health Officials
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.